These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 17250864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
    Neubauer A, Beer M, Brandmüller C, Kaaden OR, Osterrieder N.
    Virology; 1997 Dec 08; 239(1):36-45. PubMed ID: 9426444
    [Abstract] [Full Text] [Related]

  • 3. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence.
    Thormann N, Van de Walle GR, Azab W, Osterrieder N.
    Virus Res; 2012 Oct 08; 169(1):203-11. PubMed ID: 22902480
    [Abstract] [Full Text] [Related]

  • 4. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T, Kondo T, Sugita S, Damiani AM, O'Callaghan DJ, Imagawa H.
    Virology; 1998 Mar 01; 242(1):68-79. PubMed ID: 9501037
    [Abstract] [Full Text] [Related]

  • 5. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
    Osterrieder N, Neubauer A, Brandmüller C, Kaaden OR, O'Callaghan DJ.
    Virology; 1996 Dec 15; 226(2):243-51. PubMed ID: 8955044
    [Abstract] [Full Text] [Related]

  • 6. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
    Neubauer A, Meindl A, Osterrieder N.
    Berl Munch Tierarztl Wochenschr; 1999 Sep 15; 112(9):351-4. PubMed ID: 10507185
    [Abstract] [Full Text] [Related]

  • 7. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
    von Einem J, Wellington J, Whalley JM, Osterrieder K, O'Callaghan DJ, Osterrieder N.
    J Virol; 2004 Mar 15; 78(6):3003-13. PubMed ID: 14990719
    [Abstract] [Full Text] [Related]

  • 8. Argentine strain of equine herpesvirus 1 isolated from an aborted foetus shows low virulence in mouse respiratory and abortion models.
    Galosi CM, Barbeito CG, Vila Roza MV, Cid de la Paz V, Ayala MA, Corva SG, Etcheverrigaray ME, Gimeno EJ.
    Vet Microbiol; 2004 Oct 05; 103(1-2):1-12. PubMed ID: 15381260
    [Abstract] [Full Text] [Related]

  • 9. Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus).
    Huang J, Hartley CA, Ficorilli NP, Crabb BS, Studdert MJ.
    Arch Virol; 2005 Dec 05; 150(12):2583-92. PubMed ID: 16052277
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread.
    Neubauer A, Braun B, Brandmuller C, Kaaden OR, Osterrieder N.
    Virology; 1997 Jan 20; 227(2):281-94. PubMed ID: 9018127
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N, Van de Walle GR.
    Vet Microbiol; 2010 Jun 16; 143(1):21-8. PubMed ID: 20202764
    [Abstract] [Full Text] [Related]

  • 13. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
    Smith PM, Kahan SM, Rorex CB, von Einem J, Osterrieder N, O'Callaghan DJ.
    J Virol; 2005 Apr 16; 79(8):5105-15. PubMed ID: 15795295
    [Abstract] [Full Text] [Related]

  • 14. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL, Damiani A, Osterrieder N, Wagner B.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):266-74. PubMed ID: 21349590
    [Abstract] [Full Text] [Related]

  • 15. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice.
    Marshall KR, Sun Y, Brown SM, Field HJ.
    Virology; 1997 Apr 28; 231(1):20-7. PubMed ID: 9143298
    [Abstract] [Full Text] [Related]

  • 16. The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model.
    Kasem S, Yu MH, Yamada S, Kodaira A, Matsumura T, Tsujimura K, Madbouly H, Yamaguchi T, Ohya K, Fukushi H.
    Virology; 2010 May 10; 400(2):259-70. PubMed ID: 20199788
    [Abstract] [Full Text] [Related]

  • 17. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):59-66. PubMed ID: 16473414
    [Abstract] [Full Text] [Related]

  • 18. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo.
    Van de Walle GR, May ML, Sukhumavasi W, von Einem J, Osterrieder N.
    J Immunol; 2007 Sep 15; 179(6):4161-9. PubMed ID: 17785855
    [Abstract] [Full Text] [Related]

  • 19. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.
    Frampton AR, Smith PM, Zhang Y, Matsumura T, Osterrieder N, O'Callaghan DJ.
    Virus Res; 2002 Dec 15; 90(1-2):287-301. PubMed ID: 12457983
    [Abstract] [Full Text] [Related]

  • 20. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
    Csellner H, Walker C, Wellington JE, McLure LE, Love DN, Whalley JM.
    Arch Virol; 2000 Dec 15; 145(11):2371-85. PubMed ID: 11205124
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.